Sign in

CIK 0001619856

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453728228
Phone
+1 510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
  1. 4 Open-market sale Chief Scientific Officer sold 3,564 shares at $1.35 ($4,811)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Chief Financial Officer bought 17,360 shares at $1.42 ($24,651)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award VP of Finance and Controller acquired 25,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Financial Officer acquired 33,000 shares (grant or award)
  17. 4 Grant or award Chief Legal Officer acquired 33,000 shares (grant or award)
  18. 4 Grant or award Chief Business Officer acquired 33,000 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 118,700 shares (grant or award)
  20. 4 Grant or award Chief Scientific Officer acquired 33,000 shares (grant or award)

Page 2 of 7 · 125 filings